Products

Direct sales of MagnetOs bone graft in the U.S. continued to grow in 3Q21, with a year-to-date increase of 119% over the same period in 2020.

NeoGenix XP more closely resembles natural bone vs. synthetic materials, such as hydroxyapatite or tricalcium phosphate.

The company seeks to supply effective bone void fillers for patients with an exhausted bone metabolism.

The investment will be used to extend CoreBone's commercial global presence, primarily in China, with coral-based bone graft.

Opus Mg Set is a magnesium-based settable bone void filler for orthopedic procedures.

The first patient has been treated in a study to investigate OssDsign Catalyst in patients undergoing spinal fusion.

Proceeds will further advance the company's regenerative medicine pipeline of orthobiologic products.

The Phase III study with JTA-004 viscosupplement did not meet the primary and consequently the key secondary endpoints.

Published data show that i-FACTOR is not only cost-effective compared to autograft in ACDF, but is the dominant economic strategy.

OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgeries.